These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Lower respiratory tract infections: prevention using vaccines. Whitney CG; Harper SA Infect Dis Clin North Am; 2004 Dec; 18(4):899-917. PubMed ID: 15555831 [TBL] [Abstract][Full Text] [Related]
26. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus. Scheinfeld N J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H; J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703 [TBL] [Abstract][Full Text] [Related]
28. Antibiotics in childhood pneumonia. Hale KA; Isaacs D Paediatr Respir Rev; 2006 Jun; 7(2):145-51. PubMed ID: 16765302 [TBL] [Abstract][Full Text] [Related]
29. [Influenza and pneumococcal vaccination in adults]. Weinke T; Güthoff W Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S82-5. PubMed ID: 19353477 [TBL] [Abstract][Full Text] [Related]
30. Strategies for prevention of community-acquired pneumonia. Arunabh ; Niederman MS Semin Respir Infect; 1998 Mar; 13(1):68-78. PubMed ID: 9543477 [TBL] [Abstract][Full Text] [Related]
32. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
33. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines. Picazo JJ Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362 [TBL] [Abstract][Full Text] [Related]
35. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. McCullers JA J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927 [TBL] [Abstract][Full Text] [Related]
37. The unmet need in the elderly: designing new influenza vaccines for older adults. McElhaney JE Vaccine; 2005 Jul; 23 Suppl 1():S10-25. PubMed ID: 15908062 [TBL] [Abstract][Full Text] [Related]
38. Reducing antibiotic use in influenza: challenges and rewards. Low D Clin Microbiol Infect; 2008 Apr; 14(4):298-306. PubMed ID: 18093237 [TBL] [Abstract][Full Text] [Related]
39. Infections in the elderly. Liang SY; Mackowiak PA Clin Geriatr Med; 2007 May; 23(2):441-56, viii. PubMed ID: 17462528 [TBL] [Abstract][Full Text] [Related]
40. The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over. Kelly H; Attia J; Andrews R; Heller RF Vaccine; 2004 Jun; 22(17-18):2192-8. PubMed ID: 15149776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]